These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 33800050)

  • 1. Exploiting the Potential of
    Rigon L; De Filippis C; Napoli B; Tomanin R; Orso G
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33800050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.
    Seranova E; Connolly KJ; Zatyka M; Rosenstock TR; Barrett T; Tuxworth RI; Sarkar S
    Essays Biochem; 2017 Dec; 61(6):733-749. PubMed ID: 29233882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    De Filippis C; Napoli B; Rigon L; Guarato G; Bauer R; Tomanin R; Orso G
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy and Lysosome Storage Disorders.
    Ren H; Wang G
    Adv Exp Med Biol; 2020; 1207():87-102. PubMed ID: 32671740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal Storage Diseases-Regulating Neurodegeneration.
    Onyenwoke RU; Brenman JE
    J Exp Neurosci; 2015; 9(Suppl 2):81-91. PubMed ID: 27081317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Dysfunction in Lysosomal Storage Disorders.
    de la Mata M; Cotán D; Villanueva-Paz M; de Lavera I; Álvarez-Córdoba M; Luzón-Hidalgo R; Suárez-Rivero JM; Tiscornia G; Oropesa-Ávila M
    Diseases; 2016 Oct; 4(4):. PubMed ID: 28933411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases.
    Luciani M; Gritti A; Meneghini V
    Front Mol Biosci; 2020; 7():224. PubMed ID: 33062642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From bedside to cell biology: a century of history on lysosomal dysfunction.
    Coutinho MF; Matos L; Alves S
    Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune system irregularities in lysosomal storage disorders.
    Castaneda JA; Lim MJ; Cooper JD; Pearce DA
    Acta Neuropathol; 2008 Feb; 115(2):159-74. PubMed ID: 17924126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.
    Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M
    Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative Lysosomal Storage Disorders: TPC2 Comes to the Rescue!
    Prat Castro S; Kudrina V; Jaślan D; Böck J; Scotto Rosato A; Grimm C
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal storage disease overview.
    Sun A
    Ann Transl Med; 2018 Dec; 6(24):476. PubMed ID: 30740407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPML1: The Ca
    Di Paola S; Scotto-Rosato A; Medina DL
    Cell Calcium; 2018 Jan; 69():112-121. PubMed ID: 28689729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematological Findings in Lysosomal Storage Disorders: A Perspective from the Medical Laboratory.
    Leal AF; Nieto WG; Candelo E; Pachajoa H; Alméciga-Díaz CJ
    EJIFCC; 2022 Apr; 33(1):28-42. PubMed ID: 35645695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
    Pisonero-Vaquero S; Medina DL
    Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting neurological abnormalities in lysosomal storage diseases.
    van Gool R; Tucker-Bartley A; Yang E; Todd N; Guenther F; Goodlett B; Al-Hertani W; Bodamer OA; Upadhyay J
    Trends Pharmacol Sci; 2022 Jun; 43(6):495-509. PubMed ID: 34844772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.